Saturday 17 October 2026
Export BPTH’s income statement to Excel — free account
Bio-Path Holdings, Inc.
BPTH Healthcare Biotechnology
In the quarter to March 2026, EPS fell 101.2% and free cash flow grew 98.7%, each against the same quarter a year earlier. Operating cash flow growth for three consecutive years.
0.00
0.00
NaN
Follow BPTH
| Older periods | Jun '25 | Sep '25 | Dec '25 | Mar '26 | |
|---|---|---|---|---|---|
Current Ratio |
+8 more quarters Free account |
0.09 | 0.08 | 0.08 | 0.07 |
Net Debt/EBITDA |
0.00 | 0.00 | — | 0.04 | |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.06 | 0.00 | — | 0.14 | |
Capex/Depreciation |
0.00 | 0.00 | — | 0.00 | |
Interest Coverage |
(130.34) | (3.75) | — | (11.88) | |
Research and Development Expense of Revenue |
0.00% | 0.00% | — | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | — | 0.00% | |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Share Based Compensation of Revenue |
0.00% | 0.00% | — | 0.00% | |
Free Cash Flow per Share |
(0.03) | 0.00 | — | 0.00 | |
Cash per Share |
0.00 | 0.00 | — | 0.00 | |
Shareholders Equity per Share |
(0.86) | (0.94) | 0.00 | (0.91) | |
Interest Debt per Share |
0.00 | 0.00 | — | 0.00 | |
Book value per Share |
(0.86) | (0.94) | 0.00 | (0.91) | |
Free Cash Flow |
(0.28) | 0.00 | — | (0.04) | |
Working Capital |
(7.18) | (8.02) | (8.22) | (8.47) | |
Net Current Asset Value |
(7.22) | (8.03) | (8.23) | (8.49) | |
| Other line items | |||||
Quick Ratio |
0.00 | 0.00 | 0.00 | 0.00 | |
Revenue per Share |
0.00 | 0.00 | — | 0.00 | |
Operating CF per Share |
(0.03) | 0.00 | — | 0.00 | |
Capex per Share |
0.00 | 0.00 | — | 0.00 | |
Average Payables |
2.12 | 2.97 | 3.09 | 3.80 | |
Average Assets |
2.93 | 1.83 | 2.28 | 1.44 | |
Average Common Equity |
(2.93) | (4.36) | (4.03) | (5.54) |
Columns are period end dates